Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction

NCT ID: NCT01156662

Last Updated: 2013-04-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

1400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-03-31

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study was designed to investigate whether the thrombus aspiration using Export Aspiration Catheter (Medtronic Corporation, California, USA) during primary percutaneous coronary intervention (PCI) in acute myocardial infarction improve clinical outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary percutaneous coronary intervention (PCI) is the preferred strategy for immediate revascularization in patients with acute ST-elevation myocardial infarction (STEMI). A meta-analysis of trials comparing primary PCI to fibrinolytic therapy showed a mortality benefit to the invasive approach. However, although TIMI III flow is achieved in the culprit epicardial vessel in the majority of patients, lack of tissue-level reperfusion is observed in approximately 30% of patients as manifested by persistence of chest pain and ST-segment elevation. Many strategies have tried to overcome this problem, from mechanical thrombectomy and distal protection devices to myocardial preserving agents. The purpose of present study is to investigate the efficacy of the thrombus aspiration using Export Aspiration Catheter (Medtronic Corporation, California, USA) during primary PCI in acute myocardial infarction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myocardial Infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No aspiration

Group Type ACTIVE_COMPARATOR

Endeavor resolute or Resolute integrity (Medtronic)

Intervention Type DEVICE

PCI without thrombus aspiration

Thrombus aspiration

Group Type ACTIVE_COMPARATOR

Export Aspiration Catheter, Endeavor resolute or Resolute integrity (Medtronic)

Intervention Type DEVICE

PCI after thrombus aspiration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endeavor resolute or Resolute integrity (Medtronic)

PCI without thrombus aspiration

Intervention Type DEVICE

Export Aspiration Catheter, Endeavor resolute or Resolute integrity (Medtronic)

PCI after thrombus aspiration

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with first ST-elevation myocardial infarction who undergo primary PCI within 12 hours after symptom onset
* Patients who are eligible for PCI

Exclusion Criteria

* History of bleeding diathesis or coagulopathy
* Pregnant
* Known hypersensitivity or contra-indication to contrast agent
* Left main disease
* In-stent restenosis lesion
* Graft vessels lesion
* Chronic total occlusion lesion
* Renal dysfunction, creatinine more than 2.0 mg/dL
* Contraindication to aspirin, clopidogrel or cilostazol
* Prior PCI or bypass surgery
* Old myocardial infarction
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic

INDUSTRY

Sponsor Role collaborator

Ajou University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Seung-Jea Tahk

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Seung-Jea Tahk, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Cardiology, Ajou University School of Medicine, Ajou University Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hallym University Sacred Heart Hospital

Anyang, , South Korea

Site Status

Sejong General Hospital

Bucheon-si, , South Korea

Site Status

Bundang CHA General Hospital

Bundang, , South Korea

Site Status

Seoul National University Bundang Hospital

Bundang, , South Korea

Site Status

Dankook University Hospital

Cheonan, , South Korea

Site Status

Soon Chun Hyang University Hospital

Cheonan, , South Korea

Site Status

Keimyung University Dongsan Hospital

Daegu, , South Korea

Site Status

Yeungnam University Medical Center

Daegu, , South Korea

Site Status

Daejeon ST. Mary's Hospital,The Catholic University of Korea

Daejeon, , South Korea

Site Status

Konyang University Hospital

Daejeon, , South Korea

Site Status

Gangneung Asan Hospital

Gangneung, , South Korea

Site Status

Kwandong University college of Medicine Myongji Hospital

Goyang, , South Korea

Site Status

National Health Insurance Corporation ILSAN Hospital

Goyang, , South Korea

Site Status

Chonnam National University Hospital

Gwangju, , South Korea

Site Status

Inha University Hospital

Incheon, , South Korea

Site Status

Chonbuk National University Hospital

Jeonju, , South Korea

Site Status

Handong University Sunlin Hospital

Pohang, , South Korea

Site Status

Inje University Pusan Paik Hospital

Pusan, , South Korea

Site Status

Hallym University Kangdong Sacred Heart Hospital

Seoul, , South Korea

Site Status

Hallym University Kangnam Sacred Heart Hospital

Seoul, , South Korea

Site Status

Korea Univeristy Guro Hospital

Seoul, , South Korea

Site Status

Yonsei University Gangnam Severance Hospital

Seoul, , South Korea

Site Status

Yonsei University Severance Hospital

Seoul, , South Korea

Site Status

St. Carollo Hospital

Suncheon, , South Korea

Site Status

Ajou University Hospital

Suwon, , South Korea

Site Status

Ulsan University Hospital

Ulsan, , South Korea

Site Status

Yeonsei Univeristy Wonju College of Medicine Wonju Christion Hospital

Wŏnju, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ETAMI-2009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.